Basics Bicara Therapeutics Inc. Common Stock IPO Date: September 13, 2024 Sector: Healthcare Industry: Biotech Market Cap: $658.03M Activated in VL: True Average Daily Range Avg Daily Range: $0.58 | 3.89% Avg Daily Range (30 D): $0.30 | 2.66% Avg Daily Range (90 D): $0.40 | 3.53% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .24M Avg Daily Volume (90 D): .56M Trade Size Avg Trade Size (Sh.): 79 Avg Trade Size (Sh.) (30 D): 55 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 235 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $.91M Avg Inst. Trade (90 D): $1.04M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.66M Avg Closing Trade (30 D): $.61M Avg Closing Trade (90 D): $1.17M Avg Closing Volume: 122.99K     News Jun 1, 2025 @ 5:12 PM Bicara Therapeutics Demonstrates Deep and Durable ... Source: N/A May 22, 2025 @ 9:00 PM Bicara Therapeutics Announces Publication of an Ab... Source: N/A Apr 23, 2025 @ 2:00 PM Bicara Therapeutics to Present Updated Data from O... Source: N/A Sep 16, 2024 @ 8:01 PM Bicara Therapeutics Announces Closing of $362 Mill... Source: Globe Newswire Sep 16, 2024 @ 8:01 PM Bicara Therapeutics Announces Closing of $362 Mill... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $4.44 $-.5 $-.68 Diluted EPS $4.44 $-.5 $-.68 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -102.67M $ -27.39M $ -36.85M Operating Income / Loss $ -121.07M $ -32.02M $ -41.79M Cost of Revenue $ $ $ Net Cash Flow $ 285.86M $ M $ M PE Ratio 2.72